






LStandardizing definitions for hybrid coronary revascularizationRalf E. Harskamp, MD,a,e Johannes O. Bonatti, MD,b David X. Zhao, MD, PhD,c John D. Puskas, MD,d
Robbert J. de Winter, MD, PhD,e John H. Alexander, MD, MHS,a and Michael E. Halkos, MDdThe optimal revascularization strategy for patients with
multivessel coronary artery disease remains controversial. Cor-
onary artery bypass grafting (CABG) surgery is still considered
the criterion standard, but percutaneous coronary intervention
(PCI) has become the preferred strategy for most patients
with coronary artery disease.1,2 Numerous studies have
compared outcomes after CABG and multivessel PCI. In
general, it is accepted that CABG surgery has the advantage
of superior long-term freedom from repeat revascularization,
as well as a survival benefit in certain high-risk groups, but
that these benefits come at the expense of a higher risk of peri-
procedural stroke and other in-hospital complications, as well
as a longer recovery time.3-5 An alternative approach that
would combine both CABG and PCI was first developed in
the late 1990s.6 This integrated approach was subsequently
referred to as ‘‘integrated coronary revascularization’’ or
‘‘hybrid coronary revascularization’’ (HCR), in which the
term hybrid reflected the mixture of therapies drawn from
different subspecialties (CABG and PCI) that were used to
achieve coronary revascularization. The current evidence for
the use of HCR is limited to nonrandomized, single-
institution or multicenter experiences that have used various
clinical criteria and definitions, as well as techniques.7,8 For
comparative effectiveness studies, as well as for the use in
clinical practice, a more uniform definition of HCR is of
utmost importance. In this article, we will discuss the
currently used definitions and the issues that arise when
implementing these definitions, and we will propose a more
uniform definition of HCR derived from existing definitions.CURRENTLY USED DEFINITIONS
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European Society of Cardiology, have introduced
definitions for hybrid procedures in the setting of coronary
revascularization.9-13 Table 1 summarizes the various
definitions that are currently applied by these national
databases and national and international societies.
The widest definition is used by the STS, in which hybrid
procedures include all planned and unplanned combinations
of procedures that combine a surgical and transcatheter
interventional approach during a single hospital stay.9 The
guidelines of the joint American societies on PCI11 and
CABG12 use a much stricter definition for HCR, in which
procedures have to be planned and should involve a
combination of left internal thoracic artery (LITA) to left
anterior descending artery (LAD) grafting and PCI of at
least one non-LAD coronary artery. As can also be seen
in Table 1, the definition of HCR in comparison studies
registered at clinicaltrials.gov also follow these stricter joint
American society guideline definitions, suggesting that
this definition reflects the most optimal strategy for
performing HCR. The question is whether these restricted
definitions should be used or whether definitions
should be expanded to include other, less favorable,
combinations of percutaneous and surgical revasculariza-
tion techniques.THE ISSUE OF ‘‘UNPLANNED’’ HCR
PROCEDURES
There is debate regarding whether to include patients
whose procedures are considered ‘‘unplanned’’ when
surgical and percutaneous coronary revascularization are
performed in 2 stages. In the STS database, for instance,
cases were considered unplanned HCR when either PCI
or CABGwas performed after incomplete revascularization
or graft closure during the same hospital admission.9 The
inclusion of graft closure is particularly troublesome, and
in our view unplanned HCR for these cases is a misnomer
for a CABG procedure that was complicated by acute graft
failure that required a repeat intervention. The converse
misclassification may also occur, when CABG is
performed because of complications arising from PCI. In
our opinion, these cases should not be considered HCR
procedures; rather, they should be classified as complica-
tions of the index procedure. Complementarily, patients
undergoing CABG who subsequently undergo PCI
because of incompletely revascularized territories that
were not grafted should be considered as undergoing
unplanned HCR.ery c February 2014
TABLE 1. Currently used definitions for hybrid coronary revascularization
Guideline/registry Definition
2011 ACCF/AHA/SCAI Guidelines for PCI; 2011 ACCF/AHA Guidelines
for CABG11,12
The planned combination of LITA-LAD artery grafting and PCI of 1
non-LAD coronary arteries. Hybrid coronary revascularization may be
performed in a hybrid suite in a single operative setting or as a staged
procedure (PCI and CABG performed in 2 different operative suites,
separated by hours to 2 d, but typically during the same hospital stay).
2010 ESC/EACTS Guidelines on Myocardial Revascularization10 Planned, intentional combination of CABG, with a catheter-based
intervention to other coronary arteries during the same hospital stay.
Procedures can be performed consecutively in a hybrid operating room or
sequentially on separate occasions in the conventional surgical and PCI
environments.
STS Adult Cardiac Registry National Database (version 2.73)9 A hybrid procedure is defined as a procedure that combines surgical and
transcatheter interventional approaches: (1) planned, concurrent is
performed in same setting; (2) planned, staged is performed in the same
hospital admission; (3) unplanned is performed after incomplete
revascularization or graft closure during the same hospital admission.
NCDR CathPCI Registry (version 4.4)13 Hybrid therapy occurs when both surgical and percutaneous coronary
revascularization are planned, with different lesions treated with the
different techniques.
Clinicaltrials.gov (definitions by registered studies) Minimal invasive LITA-to-LAD and PCI of non-LAD lesions. Procedures
can be performed either in the same operating suite or during the same
hospitalization
ACCF, American College of Cardiology Foundation; AHA, American Heart Association; SCAI, Society for Cardiovascular Angiography and Interventions; PCI, percutaneous
coronary intervention; CABG, coronary artery bypass grafting; LITA, left internal thoracic artery; LAD, left anterior descending artery; ESC, European Society of Cardiology;
EACTS, European Association for Cardio-Thoracic Surgery; STS, Society of Thoracic Surgeons; NCDR, National Cardiovascular Data Registry.







LHCR PROCEDURES IN THE SETTING OFACUTE
ST-SEGMENT ELEVATION MYOCARDIAL
INFARCTION
It is controversial whether patients with acute
ST-segment elevation myocardial infarction who under-
went PCI (with or without stenting) for the infarct related
artery and subsequent emergency CABG through a
sternotomy of the non–infarct related coronary arteries
should be considered as having undergone HCR. This
warrants special consideration for patients in whom the
LAD was initially treated percutaneously with balloon
angioplasty only. In these patients, angioplasty is typically
used to interrupt the infarct, and the LAD is typically then
bypassed during CABG surgery. The latest European
guidelines on myocardial revascularization consider acute
ST-segment elevation myocardial infarction cases in which
primary PCI is performed for a non-LAD culprit vessel
followed by CABG for complete revascularization as
procedures performed with a ‘‘hybrid approach.’’10 The
CathPCI Registry and the STS registry consider these cases
planned hybrid procedures, as long as both procedures are
performed during the same hospital admission.13 In our
opinion, patients undergoing emergency PCI of the
infarct-related artery followed by CABG of both the
infarct-related artery and non–infarct related territories
should not be considered HCR. Patients who undergo
emergency or urgent PCI of an infarct-related artery
followed by bypass grafting of non–infarct-related
territories, however, should technically be considered asThe Journal of Thoracic and Caundergoing HCR procedures as long as the decision to
follow this approach was made before PCI was undertaken.
WHAT IF A BYPASS GRAFT OTHER THAN THE
LITA IS USED FOR HCR?
The rationale for performing HCR in most cases is to
provide revascularization to the LAD with the LITA,
because of its superior patency.14 In some cases, however,
multiple left-sided arterial grafts are performed with
either internal thoracic artery used to graft the LAD and
1 or more other left-sided targets. In these cases, PCI is
used to treat the right coronary or the remaining left
non-LAD coronary arteries. Similarly, saphenous vein
grafts may also be used to graft LAD or non-LAD left-
sided vessels, followed by PCI of remaining vessels. For
purposes of definition, these cases should be considered
hybrid cases. Currently, an increasing number of cases
are being reported in which minimally invasive double in-
ternal thoracic artery grafting is combined with PCI for
treatment of complex multivessel disease.15 A subclassifi-
cation, such as ‘‘advanced HCR’’ or ‘‘complex HCR,’’ has
been proposed for these procedures, to differentiate these
cases from HCR that uses single-vessel CABG.
WHAT IF THE SURGICAL PROCEDURE IS
PERFORMED THROUGH A CONVENTIONAL
STERNOTOMY?
Although most centers that perform HCR use minimally
invasive techniques, one should also consider the use ofrdiovascular Surgery c Volume 147, Number 2 557







L median sternotomy with LITA-LAD grafting as HCR, as
long as PCI is performed for at least 1 non-LAD lesion. A
subclassification is justified, however, because minimally
invasive techniques require a different skill set and overall
have a different risk profile and fewer complications than
do full sternotomy procedures. For example, sternal wound
complications would be nonexistent with sternal-sparing
approaches. One of the benefits of less-invasive surgical
revascularization is the potentially shorter recovery period
and faster return to normal activities associated with
sternal-sparing approaches. Several authors have shown
better quality of life scores and functional recovery
with minimally invasive HCR relative to transsternal
CABG.16-18 Therefore, although we believe that HCR
procedures should include those that use a full median
sternotomy approach, additional subclassification is
necessary to distinguish them from minimally invasive
procedures that use a partial sternotomy, lateral
thoracotomy, or thoracoscopic approach. Most of these
subclassifications already exist in the latest version of the
STS database but are lacking in the CathPCI Registry.
THE SEQUENCE AND TIME INTERVAL OF
SURGICAL AND PERCUTANEOUS PROCEDURES
HCR consists of 2 separate procedures that can be
performed in a hybrid operating room within minutes of
each other (referred to as ‘‘simultaneous,’’ ‘‘one-stage,’’
‘‘one-stop,’’ or ‘‘concurrent’’) or within hours, days, or
even weeks of each other by using the conventional
operating theater and catheterization laboratories to
perform the procedures (referred to as ‘‘2-staged’’ or
‘‘staged’’).19 Surgical revascularization is usually per-
formed first, followed by PCI, and when a 2-staged plan
is used, most centers perform the procedures within the
same hospital stay. Two-staged HCR procedures with
LITA-LAD grafting and PCI performed during separate
hospital admissions, either at the same or different
institutions, are also common occurrences. This could be
a particularly useful approach in patients with complex
disease, as well as in patients with specific comorbidities,
such as renal failure, for whom 2-staged HCR could
potentially lower the risk of periprocedural complications
associated with surgery and PCI. HCR procedures
performed at different institutions may increase adoption
of HCR as a mainstream revascularization option, because
interventional cardiologists can perform the PCI in their
own referring centers. From a research perspective, these
cases pose a number of challenges related to data capturing.
Current national registries, such as the CathPCI Registry
and the STS database, define HCR as a combination of
CABG and PCI procedures that occur during the same
hospital stay. When HCR is performed in 2 different
hospitals or during 2 hospitalizations, some staged HCR
cases may currently be misclassified because the second558 The Journal of Thoracic and Cardiovascular Surgpart of HCR is considered a repeat revascularization
procedure, even though the intention to treat was HCR.
Therefore we believe that these combinations of procedures
should be considered HCR irrespective of the sequence and
timing if the intent to treat is HCR procedure, as long as
both procedures occur within 60 days of each other and
the second stage of the procedure is elective. Patients who
are seen urgently before to their second stage because of
interim ischemia should be classified as undergoing a repeat
intervention. Although this definition could be used in
clinical trials as well as registries with longitudinal
follow-up, or those that document the intent to perform
HCR in addition to whether HCR is actually performed,
the usefulness of this definition in the STS database and
CathPCI Registry is limited, because patients in these
registries are only followed up during index hospitalization
or to 30 days. Thus patients for whom the second stage of
the HCR procedure is performed after index hospitalization
or after 30 days are unlikely to be captured. This same
limitation applies to patients who undergo PCI first during
a separate hospitalization. Whether these patients are
being captured as undergoing HCR in either the CathPCI
Registry or STS database is unclear and depends on
accurate documentation and coding, and this is an
important limitation of current database comparisons for
2-staged HCR procedures with other revascularization
strategies.KEY ELEMENTS FOR HCR
The principle element that determines HCR is that a
combination of surgical and percutaneous techniques is
chosen with the a priori intent of providing complete
coronary revascularization, with the 2 procedures scheduled
and performed within a predefined period (Figure 1). This
means that HCR should always be defined on an
intent-to-treat basis, which requires that the use of a hybrid
approach be discussed before the performance of either
surgical or percutaneous coronary revascularization.
In summary, we propose the following classification
system for HCR for patients with multivessel coronary
artery disease:
1. Planned use of CABG and PCI techniques for
revascularization of different coronary territories
2. Both stages of HCR procedures being performed within
60 days of each other, either during the same or different
hospital encounters, regardless of each procedure’s
location
3. Neither the CABG nor PCI portion of the procedure
being performed for complications of either procedure
4. Inclusion of both 1-stage and 2-stage approaches, with
either LITA-LAD grafting or PCI performed first
5. Inclusion of any of scenarios 1 through 4 regardless of
surgical approach (choice of incision)ery c February 2014
FIGURE 1. Proposed definition for hybrid coronary revascularization.
STEMI, ST-segment elevation myocardial infarction; LITA-LAD, left
internal thoracic artery to left anterior descending artery grafting; DES,
drug-eluting stent.







L6. Exclusion of cases in which patients present with
acute ST-segment elevation myocardial infarction and
undergo balloon angioplasty or stenting of the infarct-
related artery followed by multivessel CABG that
also involves revascularization of the infarct-related
territory
Subclassification of the HCR procedure should then be
based on clinical presentation, type and number of bypass
grafts used, use of minimally invasive techniques, and the
sequence and time interval of surgical and percutaneous
approaches.CONCLUSIONS
HCR encompasses the use of a variety of surgical and
percutaneous techniques to accomplish complete coronary
revascularization and ultimately improve patient outcomes.
The variability in implementation of new surgical and
percutaneous technologies, as well as clinical indications
among centers that perform HCR, creates considerable het-
erogeneity. In this article, we have proposed a standardized
definition as well as a subclassification for HCR procedures
that may be helpful not only in clinical practice but also for
clinical research. Future efforts should focus on furtherThe Journal of Thoracic and Carefining and harmonizing definitions that are currently
used by national registries.References
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